BlogHeader.png

Alcami Announces Sale of its Weert, Netherlands Facility

Next Step in Alcami’s Strategic Plan to Focus its Platform on High-Growth Market Segments

Durham, NC (USA) – January 8, 2020 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced the sale of its preclinical and early stage active pharmaceutical ingredient (API) facility in Weert, Netherlands to MercachemSyncom, a leading mid-sized European integrated drug-discovery and development contract research organization. Terms were not disclosed. 

Topics: Company News API Contract Manufacturing Services Contract Development Services

Alcami Featured in Wisconsin Biohealth Industry Profile

Alcami is featured among Wisconsin’s leading innovative global health and technology companies in a recent industry profile published by the Wisconsin Economic Development Corporation (WEDC). 

WEDC leads economic development efforts for the state by advancing and maximizing opportunities in Wisconsin for businesses, communities, and people to thrive in a globally competitive environment.

Topics: Company News CDMO Contract Manufacturing Services Contract Development Services